These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 6090721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G, Matsuo K, Uete T.
    Jpn J Antibiot; 1992 May; 45(5):489-501. PubMed ID: 1512934
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical laboratory approach for estimating effective administrative dose of cephalothin. Reevaluation of MIC break points in 4 category system of disc susceptibility test].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1989 Sep; 42(9):1900-12. PubMed ID: 2810753
    [Abstract] [Full Text] [Related]

  • 9. [Clinical laboratory approach for estimating effective administrative dose of cefsulodin].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1984 Sep; 37(9):1652-60. PubMed ID: 6439909
    [Abstract] [Full Text] [Related]

  • 10. [Clinical laboratory approach for estimating effective administrative dose of cefuzonam. Evaluation of disc susceptibility test and its interpretation system].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1988 Oct; 41(10):1407-17. PubMed ID: 3204654
    [Abstract] [Full Text] [Related]

  • 11. [Clinical laboratory approach in estimating effective administrative dose of piperacillin. Reevaluation of MIC break points in 3 and 4 category systems of disc susceptibility test].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1990 Sep; 43(9):1559-71. PubMed ID: 2262963
    [Abstract] [Full Text] [Related]

  • 12. [A study on the disc sensitivity test for cefmenoxime].
    Kanazawa Y, Kuramata T, Matsumoto K.
    Jpn J Antibiot; 1984 Jan; 37(1):176-83. PubMed ID: 6328060
    [Abstract] [Full Text] [Related]

  • 13. [Clinical laboratory approach in estimating the effective dosage of cefamandole].
    Uete G, Matsuo K, Uete T.
    Jpn J Antibiot; 1988 Jun; 41(6):631-40. PubMed ID: 3221428
    [Abstract] [Full Text] [Related]

  • 14. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [Abstract] [Full Text] [Related]

  • 15. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K, Fukayama S, Nishimura Y, Nishike A, Oda S, Sato S, Matsumoto Y, Ikegami R, Yokota N, Tanaka S.
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [Abstract] [Full Text] [Related]

  • 16. [Clinical laboratory approach for estimating effective administrative dose of tobramycin. Reevaluation of in vitro MIC break points of disk susceptibility test].
    Uete G, Matsuo K, Uete T.
    Jpn J Antibiot; 1989 Sep; 42(9):1888-99. PubMed ID: 2810752
    [Abstract] [Full Text] [Related]

  • 17. [Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1994 Aug; 47(8):1041-52. PubMed ID: 7933533
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [Abstract] [Full Text] [Related]

  • 19. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO, Bryskier A, Izard D, Leclerc H.
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K, Tsuzaki Y, Furukawa S, Uete T.
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.